Otros idiomas Insmed Incorporated

Acciones

INSM

US4576693075

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:01 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
25,55 ^USD	-0,43 %		+3,02 %	-17,55 %

23/04	INSMED INCORPORATED : El Truist Securities continua con su recomendación de compra	ZM
11/04	INSMED INCORPORATED : recomendación de compra de Barclays	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	03/05
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024	25/04
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	08/04
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/04
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference	28/03
Insmed Incorporated to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference	27/03
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	06/03
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/03
Actress Jane Seymour and Insmed Raise Awareness of 'Unseenism' and Empower People to Speak Up When It Comes to Their Health	29/02
Insmed To Present at Three March Conferences	29/02
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health	28/02
Insmed's Q4 Loss Widens, Revenue Rises	22/02
Insmed: Q4 Earnings Snapshot	22/02
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update	22/02
Insmed Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Insmed Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Insmed Incorporated Reiterates Sales Guidance for the Full-Year 2024	22/02
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024	08/02
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	02/02
Insmed Insider Sold Shares Worth $620,089, According to a Recent SEC Filing	05/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Insmed Incorporated

Acciones

INSM

US4576693075

Otros idiomas

Filtros